Skip to main content

Detection of New Point Mutations of BRCA1 and BRCA2 in Breast Cancer Patients

Biochemical Genetics volume 52, pages 15–28 (2014)Cite this article

Abstract

This study included 20 selected female patients with breast cancer, 30 of their female relatives (sisters and daughters), and 10 healthy females as a control group. Genomic DNA was extracted from peripheral blood lymphocytes of all the subjects, and the polymerase chain reaction was carried out using specific primers for BRCA1 (exons 2 and 8) and BRCA2 (exons 9, 11, and 21). The mutations were detected using a single-strand conformation polymorphism assay and heteroduplex analysis. Finally, the sample variants and their controls were sequenced. Mutations were detected in 44% of the study population, with 18% found in the BRCA1 gene and 26% attributed to BRCA2. Five sequence variants were identified, including two frameshift mutations, one nonsense mutation, and two missense mutations. Therefore, we conclude that germline mutations in two major genes, BRCA1 and BRCA2, may have an important influence on the predisposition and development of familial breast cancer.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  • American Society of Clinical Oncology (2003) Policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21:2397–2406

    Article  Google Scholar 

  • Barkardottir RB, Sarantaus L, Arason A, Vehmanen P, Bendahl PO, Kainu T, Syrjäkoski K, Krahe R, Huusko P, Pyrhönen S, Holli K, Kallioniemi OP, Egilsson V, Kere J, Nevanlinna H (2001) Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families. Eur J Hum Genet 9:773–779

    CAS  PubMed  Article  Google Scholar 

  • Bicka L, Kuzmak J, Rola M, Beier D (2002) Detection of genetic diversity among bovine leukemia virus population by single-strand conformational polymorphism analysis. Bull Vet Inst Pulawy 46:205–212

    Google Scholar 

  • Boakye DA, Tang J, Truc P, Merriweather A, Unnasch TR (1999) Identification of blood meals in haematophagous Diptera by cytochrome B heteroduplex analysis. Med Vet Entomol 13:282–287

    CAS  PubMed  Article  Google Scholar 

  • Calzone KA, Stopfer J, Blackwood A (1997) Establishing a cancer risk evaluation program. Cancer Pract 5:228–233

    CAS  PubMed  Google Scholar 

  • Claus EB (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318–2324

    CAS  PubMed  Article  Google Scholar 

  • Couch JF, DeShano ML, Blackwood MA (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409–1415

    CAS  PubMed  Article  Google Scholar 

  • Deng CX (2006) BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 34:1416–1427

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Eachkoti R, Hussain I, Afroze D, AejazAziz S, Jan M, Shah ZA, Das BC, Siddiqi MA (2007) BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area. Cancer Lett 248:308–320

    CAS  PubMed  Article  Google Scholar 

  • Easton DF, Bishop DT, Ford D (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 52:678–701

    CAS  PubMed Central  PubMed  Google Scholar 

  • Easton DF, Ford D, Bishop DT (1995) The Breast Cancer Linkage Consortium: breast and ovarian cancer incidence in BRCA1 mutation carriers. Am J Hum Genet 56:265–571

    CAS  PubMed Central  PubMed  Google Scholar 

  • El Gezeery A, Mahmud N, Moustafa A, Mahrous H, Mahmoud H, Abd El-Menam N (2008) BRCA1 gene mutation in familial breast cancer. Turkish J Cancer 38:167–174

  • Ferlay J, Bray F, Pisani P, Parkin DM (2004) Globocan 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base 5, version 2.0. IARC Press, Lyon

  • Goldgar DE, Easton DF, Deffenbaugh AM (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75:535–544

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684–1689

    CAS  PubMed  Article  Google Scholar 

  • Ibrahim SS, Hafez EE, Hashishe MM (2010) Presymptomic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor gene mutation detection. J Exp Clin Cancer Res 29:1–10

    Article  Google Scholar 

  • Johannesdottir G, Gudmundsson J, Bergthorsson JT, Arason A, Agnarsson BA, Eiriksdottir G, Johannsson OT, Borg A, Ingvarsson S, Easton DF, Egilsson V, Barkardottir R (1996) High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 56:3663–3665

    CAS  PubMed  Google Scholar 

  • Johnson NC, Dan HC, Cheng JQ (2004) Loss of XIAP in BRCA1 185delAG human ovarian surface epithelial cells results in aberrant active caspase 3 ubiquitination. Exp Cell Res 298:9–16

    CAS  PubMed  Article  Google Scholar 

  • King MC, Marks JH, Mandell JB (2003) Breast and ovarian risks due to the inherited mutations in BRCA1 and BRCA2. Science 302:643–646

    CAS  PubMed  Article  Google Scholar 

  • Kumar BV, Lakhotia S, Ankathil1R, Madhavan J, Jayaprakash PG, Nair MK, Somasundaram K (2002) Germline BRCA1 mutation analysis in Indian breast/ovarian cancer families. Cancer Biol Ther 1:18–23

  • Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71

    CAS  PubMed  Article  Google Scholar 

  • Nagi SA, Mazen K, Toufic E, Abdul Rahman, EK, Maya C, Fady G (2007) Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int J Surg 5:33–225

    Google Scholar 

  • Narod SA (2006) Modifiers of risk of hereditary breast cancer. Oncogene 25:5832–5836

    CAS  PubMed  Article  Google Scholar 

  • Nelson HD, Huffman LH, Fu R, Harris EL (2005) Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Prevention Services Task Force. Ann Intern Med 143:362–379

    CAS  PubMed  Article  Google Scholar 

  • Omar S, Khaled H, Gaafar R, Zekry AR, Eissa S, El-Khatib O (2003) Breast cancer in Egypt: a review of disease presentation and detection strategies. East Mediterr Health J 9:448–463

    CAS  PubMed  Google Scholar 

  • Parvin GD, Sankaran S (2006) The BRCA1 E3 ubiquitin ligase controls centrosome dynamics. Cell Cycle 5:1946–1950

    CAS  PubMed  Article  Google Scholar 

  • Santarosa M, Dolcetti R, Magri MD (1999) BRCA1 and BRCA2 gene: role in hereditary breast and ovarian cancer in Italy. Int J Cancer 83:5–9

    CAS  PubMed  Article  Google Scholar 

  • Szabo C, Masiello A, Ryan JF, Brody LC (2000) The breast cancer information core: database design, structure, and scope. Hum Mutat 16:123–131. http://research.nhgri.nih.gov/projects/bic/Member/index.shtml. Accessed 25 Feb 2013

  • Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Mitchell JT, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder SC, Steele L, Stringfellow M, Stroup C, Swedlund B, Swense J, Teng D, Thomas A, Tran T, Tranchant M, Weaver-Feldhaus J, Wong AK, Shizuya H, Eyfjord JE, Cannon-Albright L, Tranchant M, Labrie F, Skolnick MH, Weber B, Kamb A, Goldgar DE (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12:333–337

    CAS  PubMed  Article  Google Scholar 

  • Tavtigian SV, Thomas A, Frank TS, Skolnick MH (1998) The BRCA1 gene and its protein product: characterization, therapeutic and diagnostic implications. Adv Oncol 14:3–13

    Google Scholar 

  • Tavtigian SV, Samollow PB, de Silva D (2006) An analysis of unclassified missense substitutions in human BRCA1. Fam Cancer 5:77–88

    CAS  PubMed  Article  Google Scholar 

  • Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ogmundsdottir HM, Eyfjord JE (1996) A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13:117–119

    CAS  PubMed  Article  Google Scholar 

  • Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjord JE (1998) Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 352:1337–1339

    CAS  PubMed  Article  Google Scholar 

  • Tonin P, Weber B, Offit K, Couch F, Rebbeck T, Neuhausen S (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2:1179–1183

    CAS  PubMed  Article  Google Scholar 

  • Tulinius H, Olafsdottir GH, Sigvaldason H, Arason A, Barkardottir RB, Egilsson V, Ogmundsdottir HM, Tryggvadottir L, Gudlaugsdottir S, Eyfjord JE (2002) The effect of a single BRCA2 mutation on cancer in Iceland. J Med Genet 39:457–462

    CAS  PubMed  Article  Google Scholar 

  • Walsh T, King MC (2007) Ten genes for inherited breast cancer. Cancer Cell 11:103–105

    CAS  PubMed  Article  Google Scholar 

  • Yoshida K, Miki Y (2004) Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci 95:866–871

    CAS  PubMed  Article  Google Scholar 

  • Zou W (2005) Immunosuppressive networks in the tumor environment and their therapeutic relevance. Nat Rev Cancer 5:263–274

    CAS  PubMed  Article  Google Scholar 

Download references

Author information

Author notes

  1. Mahmoud Balbaa

    Present address: Faculty of Science, Beirut Arab University, Beirut, Lebanon

Affiliations

  1. Department of Molecular and Cellular Biology, Faculty of Science, University of Jijel, Jijel, Algeria

    Moufida Bensam

  2. Genetic Engineering Unit, Scientific Research City, Borg Al-Arab, Alexandria, Egypt

    Elsayed Hafez

  3. Department of Biochemistry, Faculty of Science, Alexandria University, Alexandria, Egypt

    Doaa Awad, Muhammad El-Saadani & Mahmoud Balbaa

Authors
  1. Moufida Bensam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elsayed Hafez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Doaa Awad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Muhammad El-Saadani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mahmoud Balbaa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mahmoud Balbaa.

Additional information

GenBank accession nos.

These sequence variants and their controls have been submitted to GenBank: HQ221559, HQ221560, HQ221561, HQ221562, 1260166, 1259889, HQ221557, HQ221558, HQ221555, and HQ221556.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bensam, M., Hafez, E., Awad, D. et al. Detection of New Point Mutations of BRCA1 and BRCA2 in Breast Cancer Patients. Biochem Genet 52, 15–28 (2014). https://doi.org/10.1007/s10528-013-9623-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10528-013-9623-8

Keywords

  • Point mutations
  • Genomic DNA
  • BRCA1
  • BRCA2
  • Breast cancer